Myelodysplastic syndromes (MDS): 1 mg/kg once every 3 weeks
Extravasation Prevention: Our team takes measures to prevent leakage of fluids outside the vein, avoiding tissue damage and discomfort
PMID 16029679 Pharmaceutics
*Correspondence: Prachi Pandey, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, Delhi 110067, India [email protected] This article was submitted to Environmental Toxicology, a section of the journal Frontiers in Environmental Science Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Lee B-J, Tseng Y-F, Yen C-H, Lin P-T